Integra LifeSciences Holdings Corporation (IART)
USD 22.16
(-3.78%)
USD 22.16
(-3.78%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.54 Billion | 1.55 Billion | 1.54 Billion | 1.37 Billion | 1.51 Billion | 1.47 Billion |
| Cost of Revenue | 653.18 Million | 587.35 Million | 597.8 Million | 520.83 Million | 564.68 Million | 571.49 Million |
| Gross Profit | 888.39 Million | 970.31 Million | 944.64 Million | 851.03 Million | 952.87 Million | 900.94 Million |
| Operating Expenses | 836.39 Million | 731.39 Million | 747.41 Million | 699.66 Million | 794.2 Million | 789.94 Million |
| Selling, General and Administrative Expenses | 592.64 Million | 616.31 Million | 637.44 Million | 594.52 Million | 687.59 Million | 690.74 Million |
| Research and Development Expenses | 174.59 Million | 101.19 Million | 93.05 Million | 77.38 Million | 79.57 Million | 78.04 Million |
| Other Expenses | 69.15 Million | 13.88 Million | 16.91 Million | 27.75 Million | 27.02 Million | 8.28 Million |
| Cost and Expenses | 1.43 Billion | 1.31 Billion | 1.34 Billion | 1.22 Billion | 1.35 Billion | 1.36 Billion |
| Operating Income | 111.52 Million | 238.92 Million | 197.23 Million | 151.37 Million | 178.97 Million | 110.99 Million |
| Interest Expense | 51.37 Million | 49.59 Million | 50.39 Million | 71.58 Million | 53.95 Million | 64.68 Million |
| Income Tax Expense | 13.32 Million | 33.34 Million | 45.6 Million | -40.37 Million | 9.9 Million | -3.39 Million |
| Earnings before Tax | 81.06 Million | 213.89 Million | 214.67 Million | 93.52 Million | 60.1 Million | 57.4 Million |
| Net Income | 67.74 Million | 180.55 Million | 169.07 Million | 133.89 Million | 50.2 Million | 60.8 Million |
| Earnings Per Share Basic | 0.87 | 2.18 | 2.00 | 1.58 | 0.59 | 0.73 |
| Earnings Per Share Diluted | 0.84 | 2.16 | 1.98 | 1.57 | 0.58 | 0.72 |
| Weighted Average Shares Outstanding | 78.16 Million | 82.99 Million | 84.69 Million | 84.65 Million | 85.63 Million | 82.85 Million |
| Weighted Average Shares Outstanding (Diluted) | 80.33 Million | 83.51 Million | 85.48 Million | 85.22 Million | 86.49 Million | 84.44 Million |
| Gross Margin | 0.58 | 0.62 | 0.61 | 0.62 | 0.63 | 0.61 |
| EBIT Margin | 0.25 | 0.18 | 0.16 | 0.14 | 0.14 | 0.10 |
| Profit Margin | 0.04 | 0.12 | 0.11 | 0.10 | 0.03 | 0.04 |
| EBITDA | 383.56 Million | 391.1 Million | 366.33 Million | 267.93 Million | 231.02 Million | 241.03 Million |
| Earnings Before Tax Margin | 0.07 | 0.15 | 0.13 | 0.11 | 0.12 | 0.08 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 380.83 Million | 418.17 Million | 368.87 Million | 397.03 Million | 1.54 Billion | 382.42 Million |
| Cost of Revenue | 176.97 Million | 185.7 Million | 162.03 Million | 163.06 Million | 653.18 Million | 164.07 Million |
| Gross Profit | 203.85 Million | 232.47 Million | 206.83 Million | 233.97 Million | 888.39 Million | 218.34 Million |
| Operating Expenses | 204.62 Million | 197.21 Million | 202.87 Million | 178.09 Million | 714.31 Million | 191.75 Million |
| Selling, General and Administrative Expenses | 177.19 Million | 172.18 Million | 165.79 Million | 147.44 Million | - | 161.94 Million |
| Research and Development Expenses | 27.43 Million | 25.03 Million | 26.96 Million | 24.31 Million | - | 26.59 Million |
| Other Expenses | - | 1.43 Million | -610 Thousand | -6.34 Million | -40.03 Million | 471 Thousand |
| Cost and Expenses | 388.98 Million | 382.92 Million | 364.9 Million | 341.15 Million | 1.36 Billion | 355.82 Million |
| Operating Income | -8.15 Million | 35.25 Million | 3.96 Million | 55.88 Million | 174.07 Million | 26.59 Million |
| Interest Expense | -19.37 Million | 18.65 Million | 13.62 Million | 18.87 Million | 71.83 Million | 13.06 Million |
| Income Tax Expense | -9.66 Million | -2.78 Million | -1.94 Million | 9.02 Million | 13.32 Million | -888 Thousand |
| Earnings before Tax | -20.36 Million | -15.18 Million | -5.23 Million | 28.85 Million | 81.06 Million | 18.6 Million |
| Net Income | -10.69 Million | -12.4 Million | -3.28 Million | 19.83 Million | 67.74 Million | 19.49 Million |
| Earnings Per Share Basic | -0.14 | -0.16 | -0.04 | 0.25 | - | 0.24 |
| Earnings Per Share Diluted | -0.14 | -0.16 | -0.04 | 0.25 | - | 0.24 |
| Weighted Average Shares Outstanding | 76.44 Million | 77.4 Million | 77.73 Million | 78.32 Million | 80.08 Million | 79.69 Million |
| Weighted Average Shares Outstanding (Diluted) | 76.44 Million | 77.4 Million | 77.73 Million | 78.32 Million | 80.33 Million | 79.81 Million |
| Gross Margin | 0.54 | 0.56 | 0.56 | 0.59 | 0.58 | 0.57 |
| EBIT Margin | -0.02 | 0.17 | 0.11 | 0.22 | - | 0.09 |
| Profit Margin | -0.03 | -0.03 | -0.01 | 0.05 | 0.04 | 0.05 |
| EBITDA | -8.15 Million | 72.03 Million | 38.96 Million | 86.4 Million | - | 34.87 Million |
| Earnings Before Tax Margin | -0.02 | 0.08 | 0.01 | 0.14 | 0.11 | 0.07 |
CPAC
4378
PVSP
9969
0623
102940